LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 3 | 492 | 0.0061 | -0.7324 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 11.18 | 84.90 | 1060 | 492 | 2.1529 | 1.7062 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 996 | 531 | 1.8757 | 1.5369 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 814 | 531 | 1.5330 | 1.3506 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 38 | 531 | 0.0716 | -0.2621 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.88 | 84.90 | 1104 | 531 | 2.0791 | 1.6376 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1057 | 663 | 1.5933 | 1.3401 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 843 | 663 | 1.2707 | 1.1682 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 416 | 663 | 0.6271 | 0.7088 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 14.58 | 84.90 | 1150 | 663 | 1.7335 | 1.4076 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 1083 | 766 | 1.4123 | 1.2297 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 2 | 766 | 0.0026 | -0.6929 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 856 | 766 | 1.1162 | 1.0705 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 664 | 766 | 0.8659 | 0.9113 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 16.29 | 84.90 | 1164 | 766 | 1.5179 | 1.2809 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 1 | 898 | 0.0011 | -0.7287 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 1100 | 898 | 1.2236 | 1.1221 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 2 | 898 | 0.0022 | -0.6675 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 898 | 898 | 0.9989 | 0.9994 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.99 | 84.90 | 736 | 898 | 0.8187 | 0.8859 | MN20160318_Q02 | K06 |